Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2014-04-06 Capital/Financing Update
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Other Report or Announcement
Capital/Financing Update Classification · 95% confidence The document is a short regulatory filing (1891 characters) from XTL BIOPHARMACEUTICALS LTD, reported via MAGNA. It explicitly states it is a 'Complementary report for a report sent on date 03/04/2014' and that it is attaching a report on 'FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933.' Since the document itself is an announcement or supplement regarding the filing of a major registration statement (F-3), and not the full registration statement or a standard periodic report (like 10-K or IR), it fits best under the general category for regulatory announcements that don't fit specific types. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for miscellaneous regulatory updates, although 'CAP' (Capital/Financing Update) might be considered due to the F-3 context, RNS is safer for general regulatory announcements not explicitly covered elsewhere. However, an F-3 Registration Statement is fundamentally related to capital raising/offering activities. Since 'CAP' covers 'company fundraising, financing activities, or capital structure changes,' and an F-3 is the mechanism for registering securities for sale, CAP is a stronger fit than the generic RNS, especially since the document explicitly mentions the F-3 form.
2014-04-06 English
FORM F-3/A
Regulatory Filings
2014-04-04 English
Regulatory Filings 2014
Regulatory Filings
2014-04-03 English
Other Report or Announcement
Regulatory Filings
2014-04-03 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 95% confidence The document is very short (1677 chars) and explicitly states that an attachment is included: "Attached hereto is a report on *FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933*". This structure—a brief announcement pointing to a specific regulatory document—fits the definition of a Report Publication Announcement (RPA). While the attachment is a Form F-3 (a US SEC filing), in the context of the provided classification codes, this announcement serves to publish a report. Since 'RPA' covers announcements regarding the publication of reports, it is the most appropriate fit based on the 'MENU VS MEAL' rule, rather than classifying it as a generic 'RNS' or trying to map the F-3 to a specific Israeli filing type not listed.
2014-04-03 English
Report of Periodic or Interim Report
Annual Report Classification · 100% confidence The document is titled 'FORM 20-F' and is filed with the United States Securities and Exchange Commission (SEC). It explicitly states it is an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended December 31, 2013. The content includes detailed financial data, management discussion, risk factors, and financial statements, which are typical components of an annual report. The length of the document (15,000 characters) and the presence of comprehensive financial information confirm it is the full report, not just an announcement or certification. Therefore, the appropriate classification is Annual Report (10-K). FY 2013
2014-04-03 Hebrew (modern)

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.